{"id":236242,"date":"2026-09-09T10:30:37","date_gmt":"2026-09-09T05:00:37","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=236242"},"modified":"2026-09-09T10:32:39","modified_gmt":"2026-09-09T05:02:39","slug":"dr-agarwals-health-care-q2-results-fy27-preview-date-expectations-2","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/dr-agarwals-health-care-q2-results-fy27-preview-date-expectations-2\/","title":{"rendered":"Dr Agarwal&#8217;s Health Care Q2 Results FY27 Preview: Results Date, Expectations and the Numbers That Will Decide the September 2026 Quarter"},"content":{"rendered":"<p style=\"border-left: 4px solid #1F4E79; background: #EBF3FB; padding: 10px 16px; font-style: italic;\"><em>Dr Agarwal&#8217;s Health Care share price Rs 518.05 on 9 September 2026, down 0.32%. Q2 FY27 results date not confirmed. Q1 FY27 net profit Rs 55.02 crore. Q2 FY26 base a profit of Rs 36.49 crore.<\/em><\/p>\n<div style=\"background: #F0F9FF; border-left: 4px solid #2E7D32; border-radius: 6px; padding: 14px 18px; margin: 18px 0;\">\n<p style=\"margin: 0; color: #1f4e79; font-size: 14px;\"><strong>Quick Answer<\/strong><\/p>\n<p style=\"margin: 8px 0 0;\">The Dr Agarwal&#8217;s Health Care Q2 results date for FY27 is not confirmed, and Dr. Agarwal&#8217;s Health Care Ltd. had not filed a board meeting intimation with the NSE or BSE as of 9 September 2026. Indian listing rules require the September 2026 quarter results to be published within 45 days of the quarter end, an outer deadline of 14 November 2026. The quarter will be measured against a September 2025 base of Rs 506.62 crore in revenue and a profit of Rs 36.49 crore. This preview uses reported actuals only and carries no estimated revenue or profit figure for the coming quarter.<\/p>\n<\/div>\n<p>The Dr Agarwal&#8217;s Health Care Q2 results FY27 announcement is the next scheduled earnings event for <a href=\"https:\/\/univest.in\/stocks\/agarwaleye\/dr-agarwals-health-care-l-share-price-today\">Dr. Agarwal&#8217;s Health Care Ltd.<\/a>, India&#8217;s largest eye care hospital chain, running a network of specialty ophthalmology facilities alongside optical and pharmaceutical retail. The stock traded at Rs 518.05 on the NSE on 9 September 2026, down 0.32% from the previous close of Rs 519.70, about 8.8% below its 52-week high of Rs 568.00 and 29.2% above its 52-week low of Rs 401.00.<\/p>\n<p>What makes the Dr Agarwal&#8217;s Health Care Q2 results print worth watching is the base it faces. The September 2025 quarter delivered Rs 506.62 crore of revenue and a profit of Rs 36.49 crore, while the most recent quarter on record, Q1 FY27, produced Rs 620.43 crore and a profit of Rs 55.02 crore. Everything below is built from those reported figures rather than from any forecast.<\/p>\n<p style=\"margin-top: 24px;\"><a href=\"https:\/\/univest.in\/user\/log-in?utm_source=blogs&amp;utm_medium=agarwaleye_q2_fy27\"><strong>Click Here &#8211; Get Free Investment Predictions<\/strong><\/a><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/dr-agarwals-health-care-q2-results-fy27-preview-date-expectations-2\/#When_Is_the_Dr_Agarwals_Health_Care_Q2_Results_FY27_Date\" title=\"When Is the Dr Agarwal&#8217;s Health Care Q2 Results FY27 Date?\">When Is the Dr Agarwal&#8217;s Health Care Q2 Results FY27 Date?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/dr-agarwals-health-care-q2-results-fy27-preview-date-expectations-2\/#Dr_Agarwals_Health_Care_Q2_Results_Expectations_What_the_Market_Is_Actually_Tracking\" title=\"Dr Agarwal&#8217;s Health Care Q2 Results Expectations: What the Market Is Actually Tracking\">Dr Agarwal&#8217;s Health Care Q2 Results Expectations: What the Market Is Actually Tracking<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/dr-agarwals-health-care-q2-results-fy27-preview-date-expectations-2\/#Dr_Agarwals_Health_Care_Q2_Results_Preview_The_Q1_FY27_Actuals_It_Builds_On\" title=\"Dr Agarwal&#8217;s Health Care Q2 Results Preview: The Q1 FY27 Actuals It Builds On\">Dr Agarwal&#8217;s Health Care Q2 Results Preview: The Q1 FY27 Actuals It Builds On<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/dr-agarwals-health-care-q2-results-fy27-preview-date-expectations-2\/#Q2_FY26_Base_The_Comparison_Dr_Agarwals_Health_Care_Q2_Results_FY27_Must_Beat\" title=\"Q2 FY26 Base: The Comparison Dr Agarwal&#8217;s Health Care Q2 Results FY27 Must Beat\">Q2 FY26 Base: The Comparison Dr Agarwal&#8217;s Health Care Q2 Results FY27 Must Beat<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/dr-agarwals-health-care-q2-results-fy27-preview-date-expectations-2\/#Dr_Agarwals_Health_Care_Quarterly_Results_Trend_Over_the_Last_Four_Quarters\" title=\"Dr Agarwal&#8217;s Health Care Quarterly Results Trend Over the Last Four Quarters\">Dr Agarwal&#8217;s Health Care Quarterly Results Trend Over the Last Four Quarters<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/dr-agarwals-health-care-q2-results-fy27-preview-date-expectations-2\/#Key_Factors_That_Could_Shape_Dr_Agarwals_Health_Care_Q2_Results_FY27\" title=\"Key Factors That Could Shape Dr Agarwal&#8217;s Health Care Q2 Results FY27\">Key Factors That Could Shape Dr Agarwal&#8217;s Health Care Q2 Results FY27<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/dr-agarwals-health-care-q2-results-fy27-preview-date-expectations-2\/#Centre_Additions_and_Maturity_Curve\" title=\"Centre Additions and Maturity Curve\">Centre Additions and Maturity Curve<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/dr-agarwals-health-care-q2-results-fy27-preview-date-expectations-2\/#Cataract_Volumes_and_Insurance_Mix\" title=\"Cataract Volumes and Insurance Mix\">Cataract Volumes and Insurance Mix<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/dr-agarwals-health-care-q2-results-fy27-preview-date-expectations-2\/#Very_High_Earnings_Multiple\" title=\"Very High Earnings Multiple\">Very High Earnings Multiple<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/dr-agarwals-health-care-q2-results-fy27-preview-date-expectations-2\/#Dr_Agarwals_Health_Care_Q2_Results_FY27_Share_Price_and_Valuation_Going_Into_the_Print\" title=\"Dr Agarwal&#8217;s Health Care Q2 Results FY27: Share Price and Valuation Going Into the Print\">Dr Agarwal&#8217;s Health Care Q2 Results FY27: Share Price and Valuation Going Into the Print<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/dr-agarwals-health-care-q2-results-fy27-preview-date-expectations-2\/#What_Investors_Should_Watch_When_Dr_Agarwals_Health_Care_Q2_Results_Are_Announced\" title=\"What Investors Should Watch When Dr Agarwal&#8217;s Health Care Q2 Results Are Announced\">What Investors Should Watch When Dr Agarwal&#8217;s Health Care Q2 Results Are Announced<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/dr-agarwals-health-care-q2-results-fy27-preview-date-expectations-2\/#Conclusion_on_Dr_Agarwals_Health_Care_Q2_Results_FY27\" title=\"Conclusion on Dr Agarwal&#8217;s Health Care Q2 Results FY27\">Conclusion on Dr Agarwal&#8217;s Health Care Q2 Results FY27<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/dr-agarwals-health-care-q2-results-fy27-preview-date-expectations-2\/#FAQs_on_Dr_Agarwals_Health_Care_Q2_Results_FY27\" title=\"FAQs on Dr Agarwal&#8217;s Health Care Q2 Results FY27\">FAQs on Dr Agarwal&#8217;s Health Care Q2 Results FY27<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/dr-agarwals-health-care-q2-results-fy27-preview-date-expectations-2\/#What_is_the_Dr_Agarwals_Health_Care_Q2_results_date_for_FY27\" title=\"What is the Dr Agarwal&#8217;s Health Care Q2 results date for FY27?\">What is the Dr Agarwal&#8217;s Health Care Q2 results date for FY27?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/dr-agarwals-health-care-q2-results-fy27-preview-date-expectations-2\/#What_quarter_do_the_Dr_Agarwals_Health_Care_Q2_results_2026_cover\" title=\"What quarter do the Dr Agarwal&#8217;s Health Care Q2 results 2026 cover?\">What quarter do the Dr Agarwal&#8217;s Health Care Q2 results 2026 cover?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/dr-agarwals-health-care-q2-results-fy27-preview-date-expectations-2\/#What_were_the_Dr_Agarwals_Health_Care_Q1_FY27_results\" title=\"What were the Dr Agarwal&#8217;s Health Care Q1 FY27 results?\">What were the Dr Agarwal&#8217;s Health Care Q1 FY27 results?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/dr-agarwals-health-care-q2-results-fy27-preview-date-expectations-2\/#What_were_Dr_Agarwals_Health_Care_Q2_FY26_results_in_the_September_2025_quarter\" title=\"What were Dr Agarwal&#8217;s Health Care Q2 FY26 results in the September 2025 quarter?\">What were Dr Agarwal&#8217;s Health Care Q2 FY26 results in the September 2025 quarter?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-18\" href=\"https:\/\/univest.in\/blogs-2\/dr-agarwals-health-care-q2-results-fy27-preview-date-expectations-2\/#What_are_the_main_Dr_Agarwals_Health_Care_Q2_results_expectations_this_quarter\" title=\"What are the main Dr Agarwal&#8217;s Health Care Q2 results expectations this quarter?\">What are the main Dr Agarwal&#8217;s Health Care Q2 results expectations this quarter?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-19\" href=\"https:\/\/univest.in\/blogs-2\/dr-agarwals-health-care-q2-results-fy27-preview-date-expectations-2\/#What_is_Dr_Agarwals_Health_Care_share_price_today_ahead_of_the_Q2_earnings\" title=\"What is Dr Agarwal&#8217;s Health Care share price today ahead of the Q2 earnings?\">What is Dr Agarwal&#8217;s Health Care share price today ahead of the Q2 earnings?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-20\" href=\"https:\/\/univest.in\/blogs-2\/dr-agarwals-health-care-q2-results-fy27-preview-date-expectations-2\/#Is_Dr_Agarwals_Health_Care_a_good_stock_to_buy_before_the_Q2_results\" title=\"Is Dr Agarwal&#8217;s Health Care a good stock to buy before the Q2 results?\">Is Dr Agarwal&#8217;s Health Care a good stock to buy before the Q2 results?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"When_Is_the_Dr_Agarwals_Health_Care_Q2_Results_FY27_Date\"><\/span><strong>When Is the Dr Agarwal&#8217;s Health Care Q2 Results FY27 Date?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The Dr Agarwal&#8217;s Health Care Q2 results date for FY27 is not confirmed. As of 9 September 2026, Dr. Agarwal&#8217;s Health Care Ltd. had not filed a board meeting intimation with the NSE or BSE for the September 2026 quarter, so any date circulating before that filing appears should be treated as unverified.<\/p>\n<p>What can be stated is the regulatory boundary. Listed companies in India must publish quarterly results within 45 days of the end of the quarter, which places the outer deadline for the September 2026 quarter at 14 November 2026. Companies also have to give the exchanges prior intimation of the board meeting that approves the results, so the Dr Agarwal&#8217;s Health Care Q2 results date becomes public through that filing rather than through any advance announcement.<\/p>\n<p>The Dr Agarwal&#8217;s Health Care Q2 results FY27 print covers 1 July 2026 to 30 September 2026. Small and mid-cap companies more often report in the second half of that window than in the first, so late October or early November is the range to watch for Dr Agarwal&#8217;s Health Care.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Dr_Agarwals_Health_Care_Q2_Results_Expectations_What_the_Market_Is_Actually_Tracking\"><\/span><strong>Dr Agarwal&#8217;s Health Care Q2 Results Expectations: What the Market Is Actually Tracking<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>No verified analyst estimate for the Dr Agarwal&#8217;s Health Care Q2 results FY27 quarter is in the public domain, so no revenue or profit figure should be assumed for Dr Agarwal&#8217;s Health Care. The Dr Agarwal&#8217;s Health Care Q2 results watchlist below is built from what the company has actually reported and disclosed.<\/p>\n<p>The first is the consistency of the compounding. Dr Agarwal&#8217;s Health Care lifted revenue in every one of the last five quarters, from Rs 500.81 crore to Rs 620.43 crore, and profit from Rs 38.06 crore to Rs 55.02 crore, while operating margin held near 29%.<\/p>\n<p>The second is surgical volumes and new centre additions. Hospital revenue grows through more procedures per centre and through opening new ones, and the two have different effects on margin because a new centre loses money before it fills up.<\/p>\n<p>The third is the September 2025 base of Rs 506.62 crore in revenue and Rs 36.49 crore in profit, which was the weakest profit quarter of the five. That soft base should make the year-on-year comparison look comfortable if the current run rate holds.<\/p>\n<p style=\"margin-top: 24px;\"><a href=\"https:\/\/univest.in\/screeners\"><strong>Check Dr. Agarwal&#8217;s Health Care Ltd. Live Fundamentals on the Univest Screener<\/strong><\/a><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Dr_Agarwals_Health_Care_Q2_Results_Preview_The_Q1_FY27_Actuals_It_Builds_On\"><\/span><strong>Dr Agarwal&#8217;s Health Care Q2 Results Preview: The Q1 FY27 Actuals It Builds On<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Dr. Agarwal&#8217;s Health Care Ltd. reported revenue of Rs 620.43 crore in Q1 FY27, up 23.89% from Rs 500.81 crore in Q1 FY26, and a profit of Rs 55.02 crore at the net level, up 44.56% from Rs 38.06 crore in Q1 FY26. These are reported actuals, not estimates.<\/p>\n<p>Sequentially, revenue was up 7.58% over the March 2026 quarter figure of Rs 576.69 crore, and net profit was up 10.13% from Rs 49.96 crore in Q4 FY26. Operating margin stood at 28.80% in Q1 FY27 against 28.89% in the September 2025 quarter, which is the comparison the Dr Agarwal&#8217;s Health Care Q2 results print will be read against.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Q2_FY26_Base_The_Comparison_Dr_Agarwals_Health_Care_Q2_Results_FY27_Must_Beat\"><\/span><strong>Q2 FY26 Base: The Comparison Dr Agarwal&#8217;s Health Care Q2 Results FY27 Must Beat<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Dr. Agarwal&#8217;s Health Care Ltd. reported revenue of Rs 506.62 crore and a profit of Rs 36.49 crore in Q2 FY26, the September 2025 quarter. That is the year-ago base against which the September 2026 numbers will be judged, and it is the single most useful figure in this Dr Agarwal&#8217;s Health Care Q2 results preview.<\/p>\n<p>Net profit in that base quarter was below the Rs 55.02 crore just reported for Q1 FY27, so the year-on-year comparison starts from a manageable level. Revenue of Rs 506.62 crore sits below the Rs 620.43 crore of the June 2026 quarter, which frames how much sequential movement the Dr Agarwal&#8217;s Health Care Q2 results print needs to show growth.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Dr_Agarwals_Health_Care_Quarterly_Results_Trend_Over_the_Last_Four_Quarters\"><\/span><strong>Dr Agarwal&#8217;s Health Care Quarterly Results Trend Over the Last Four Quarters<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table>\n<thead>\n<tr>\n<th>Quarter<\/th>\n<th>Revenue (Rs Cr)<\/th>\n<th>Net Profit (Rs Cr)<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>Q2 FY26 (Sep 2025)<\/td>\n<td>506.62<\/td>\n<td>36.49<\/td>\n<\/tr>\n<tr>\n<td>Q3 FY26 (Dec 2025)<\/td>\n<td>540.40<\/td>\n<td>43.63<\/td>\n<\/tr>\n<tr>\n<td>Q4 FY26 (Mar 2026)<\/td>\n<td>576.69<\/td>\n<td>49.96<\/td>\n<\/tr>\n<tr>\n<td>Q1 FY27 (Jun 2026)<\/td>\n<td>620.43<\/td>\n<td>55.02<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Figures in brackets denote negative numbers. All four quarters above are reported actuals taken from the company&#8217;s exchange filings, and they are the only basis this Dr Agarwal&#8217;s Health Care Q2 results preview uses.<\/p>\n<p>Revenue across those four quarters ranged from Rs 506.62 crore to Rs 620.43 crore, and net profit from Rs 36.49 crore to Rs 55.02 crore. That spread is the honest context for the Dr Agarwal&#8217;s Health Care Q2 results FY27 print, and it is why a single quarter should not be read as a trend on its own.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Key_Factors_That_Could_Shape_Dr_Agarwals_Health_Care_Q2_Results_FY27\"><\/span><strong>Key Factors That Could Shape Dr Agarwal&#8217;s Health Care Q2 Results FY27<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The Dr Agarwal&#8217;s Health Care Q2 results outcome will turn on a small number of company-specific variables rather than on broad market conditions. The three below are the ones visible in what Dr Agarwal&#8217;s Health Care has already reported.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Centre_Additions_and_Maturity_Curve\"><\/span><strong>Centre Additions and Maturity Curve<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Each new eye hospital takes time to reach full utilisation, so a period of rapid expansion holds margin down even when revenue grows. The split between same-centre growth and new-centre revenue is what the results commentary should address.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Cataract_Volumes_and_Insurance_Mix\"><\/span><strong>Cataract Volumes and Insurance Mix<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Cataract surgery is the volume backbone of the business, and the balance between cash-paying patients, insurance and government schemes decides realisation per procedure. That mix moves margin more than headline volume does.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Very_High_Earnings_Multiple\"><\/span><strong>Very High Earnings Multiple<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The stock trades at a price-to-earnings ratio of 89.02 against a sector average of 67.63 and 8.14 times book value, on a return on equity of 6.58%. That valuation is pricing years of expansion rather than current returns.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Dr_Agarwals_Health_Care_Q2_Results_FY27_Share_Price_and_Valuation_Going_Into_the_Print\"><\/span><strong>Dr Agarwal&#8217;s Health Care Q2 Results FY27: Share Price and Valuation Going Into the Print<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Dr Agarwal&#8217;s Health Care share price today is Rs 518.05 on the NSE, down Rs 1.65 or 0.32% from the previous close of Rs 519.70 on 9 September 2026, ahead of the Dr Agarwal&#8217;s Health Care Q2 results announcement.<\/p>\n<table>\n<thead>\n<tr>\n<th>Metric<\/th>\n<th>Value (8 September 2026)<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>NSE Symbol<\/td>\n<td>AGARWALEYE<\/td>\n<\/tr>\n<tr>\n<td>Current Market Price<\/td>\n<td>Rs 518.05<\/td>\n<\/tr>\n<tr>\n<td>52-Week High<\/td>\n<td>Rs 568.00<\/td>\n<\/tr>\n<tr>\n<td>52-Week Low<\/td>\n<td>Rs 401.00<\/td>\n<\/tr>\n<tr>\n<td>Market Capitalisation<\/td>\n<td>Rs 16,482 crore<\/td>\n<\/tr>\n<tr>\n<td>PE Ratio<\/td>\n<td>89.02<\/td>\n<\/tr>\n<tr>\n<td>Sector PE<\/td>\n<td>67.63<\/td>\n<\/tr>\n<tr>\n<td>PB Ratio<\/td>\n<td>8.14<\/td>\n<\/tr>\n<tr>\n<td>EPS (TTM)<\/td>\n<td>Rs 5.84<\/td>\n<\/tr>\n<tr>\n<td>Book Value per Share<\/td>\n<td>Rs 63.89<\/td>\n<\/tr>\n<tr>\n<td>Debt to Equity<\/td>\n<td>0.53<\/td>\n<\/tr>\n<tr>\n<td>Return on Equity<\/td>\n<td>6.58%<\/td>\n<\/tr>\n<tr>\n<td>50-Day Moving Average<\/td>\n<td>Rs 499.47<\/td>\n<\/tr>\n<tr>\n<td>200-Day Moving Average<\/td>\n<td>Rs 473.02<\/td>\n<\/tr>\n<tr>\n<td>RSI (14)<\/td>\n<td>65.44<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>The stock trades above both its 50-day average of Rs 499.47 and its 200-day average of Rs 473.02, with a 14-day RSI of 65.44. None of this is a view on where the shares go once the Dr Agarwal&#8217;s Health Care Q2 results are announced, and no price target is offered here.<\/p>\n<p style=\"margin-top: 24px;\"><em>Download the <a href=\"http:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or <a href=\"http:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&amp;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> to track Dr. Agarwal&#8217;s Health Care Ltd. live price and quarterly earnings updates.<\/em><\/p>\n<h2><span class=\"ez-toc-section\" id=\"What_Investors_Should_Watch_When_Dr_Agarwals_Health_Care_Q2_Results_Are_Announced\"><\/span><strong>What Investors Should Watch When Dr Agarwal&#8217;s Health Care Q2 Results Are Announced<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Four lines carry most of the information in a company of this size, and reading them in order keeps the Dr Agarwal&#8217;s Health Care Q2 results print in proportion.<\/p>\n<ol>\n<li>Revenue against the Rs 506.62 crore reported in the September 2025 base quarter<\/li>\n<li>Net profit against a profit of Rs 36.49 crore in that same quarter<\/li>\n<li>Operating margin against 28.80% in Q1 FY27<\/li>\n<li>Any exceptional item, provision or one-off gain disclosed alongside the numbers<\/li>\n<\/ol>\n<p>A one-off gain or provision can move the reported profit far more than operations do in a company this size, which is why the Dr Agarwal&#8217;s Health Care Q2 results announcement should be read together with the notes to the results rather than the headline alone.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Conclusion_on_Dr_Agarwals_Health_Care_Q2_Results_FY27\"><\/span><strong>Conclusion on Dr Agarwal&#8217;s Health Care Q2 Results FY27<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The Dr Agarwal&#8217;s Health Care Q2 results date is not confirmed, and 14 November 2026 is the statutory outer limit rather than an expected date. Dr. Agarwal&#8217;s Health Care Ltd. will make the schedule public through a board meeting intimation to the exchanges, and until then the September 2026 quarter can only be framed by what has already been reported.<\/p>\n<p>On that basis the Dr Agarwal&#8217;s Health Care Q2 results FY27 print faces a base of Rs 506.62 crore in revenue and a profit of Rs 36.49 crore, with the most recent quarter having delivered Rs 620.43 crore and a profit of Rs 55.02 crore. No numerical estimate appears in this preview because no verified consensus figure exists for Dr Agarwal&#8217;s Health Care, and readers should treat any preview that supplies one with caution. Verify every figure against the company filing on release and consult a SEBI-registered advisor before acting on quarterly earnings.<\/p>\n<div style=\"background: #CC0000; border-radius: 8px; padding: 16px 20px; margin: 24px 0;\">\n<p style=\"color: #ffffff; font-size: 13px; line-height: 1.7; margin: 0;\"><strong style=\"color: #ffffff;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/div>\n<h2><span class=\"ez-toc-section\" id=\"FAQs_on_Dr_Agarwals_Health_Care_Q2_Results_FY27\"><\/span><strong>FAQs on Dr Agarwal&#8217;s Health Care Q2 Results FY27<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_Dr_Agarwals_Health_Care_Q2_results_date_for_FY27\"><\/span><strong>What is the Dr Agarwal&#8217;s Health Care Q2 results date for FY27?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The Dr Agarwal&#8217;s Health Care Q2 results date for FY27 is not confirmed. Dr. Agarwal&#8217;s Health Care Ltd. had not filed a board meeting intimation with the NSE or BSE as of 9 September 2026. Indian listing rules require the September 2026 quarter results to be published by 14 November 2026 at the latest.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_quarter_do_the_Dr_Agarwals_Health_Care_Q2_results_2026_cover\"><\/span><strong>What quarter do the Dr Agarwal&#8217;s Health Care Q2 results 2026 cover?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The Dr Agarwal&#8217;s Health Care Q2 results FY27 cover 1 July 2026 to 30 September 2026, known as the September 2026 quarter. Dr. Agarwal&#8217;s Health Care Ltd. reports revenue, operating profit and net profit for that period, and the Dr Agarwal&#8217;s Health Care Q2 results filing also carries the notes to the accounts.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_were_the_Dr_Agarwals_Health_Care_Q1_FY27_results\"><\/span><strong>What were the Dr Agarwal&#8217;s Health Care Q1 FY27 results?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Dr. Agarwal&#8217;s Health Care Ltd. reported revenue of Rs 620.43 crore in Q1 FY27 and a profit of Rs 55.02 crore at the net level. Revenue was up 23.89% versus Q1 FY26 and net profit was up 44.56% from Rs 38.06 crore in Q1 FY26.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_were_Dr_Agarwals_Health_Care_Q2_FY26_results_in_the_September_2025_quarter\"><\/span><strong>What were Dr Agarwal&#8217;s Health Care Q2 FY26 results in the September 2025 quarter?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Dr. Agarwal&#8217;s Health Care Ltd. reported revenue of Rs 506.62 crore and a profit of Rs 36.49 crore in Q2 FY26. Operating margin was 28.89%. Those figures form the base for the Dr Agarwal&#8217;s Health Care Q2 results FY27 comparison.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_are_the_main_Dr_Agarwals_Health_Care_Q2_results_expectations_this_quarter\"><\/span><strong>What are the main Dr Agarwal&#8217;s Health Care Q2 results expectations this quarter?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> No verified analyst estimate is publicly available. The Dr Agarwal&#8217;s Health Care Q2 results expectations centre on revenue against the Rs 506.62 crore base, net profit against a profit of Rs 36.49 crore, operating margin against 28.80% in Q1 FY27, and any exceptional item disclosed with the numbers.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_Dr_Agarwals_Health_Care_share_price_today_ahead_of_the_Q2_earnings\"><\/span><strong>What is Dr Agarwal&#8217;s Health Care share price today ahead of the Q2 earnings?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Dr Agarwal&#8217;s Health Care share price is Rs 518.05 on the NSE as of 9 September 2026, down 0.32% from Rs 519.70. The stock is about 8.8% below its 52-week high of Rs 568.00 and 29.2% above its 52-week low of Rs 401.00, at a market capitalisation of Rs 16,482 crore.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_Dr_Agarwals_Health_Care_a_good_stock_to_buy_before_the_Q2_results\"><\/span><strong>Is Dr Agarwal&#8217;s Health Care a good stock to buy before the Q2 results?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> This article does not offer a buy, sell or hold recommendation on Dr. Agarwal&#8217;s Health Care Ltd.. The stock trades at a price-to-book ratio of 8.14 with a return on equity of 6.58%. Assess the reported numbers when they are released and consult a SEBI-registered financial advisor before making any decision.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Dr Agarwal&#8217;s Health Care Q2 results FY27 date is not yet confirmed by the exchanges. Here is the September 2026 quarter watchlist for Dr. Agarwal&#8217;s Health Care Ltd., built on actual Q1 FY27 and Q2 FY26 numbers with no invented estimates.<\/p>\n","protected":false},"author":29,"featured_media":236241,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[5331],"tags":[],"class_list":["post-236242","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-https-univest-in-blogs-category-results"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["236241"],"rank_math_title":["Dr Agarwal's Health Care Q2 Results FY27: Date, View"],"rank_math_description":["Dr Agarwal's Health Care Q2 results FY27 preview: results date status, key expectations, Q1 FY27 and Q2 FY26 actuals plus valuation before the September 2026 print."],"rank_math_focus_keyword":["Dr Agarwal's Health Care Q2 results"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"],"_edit_lock":["1788930470:23"],"_last_editor_used_jetpack":["block-editor"],"rank_math_primary_category":["5331"],"rank_math_seo_score":["79"],"_edit_last":["23"],"_ez-toc-disabled":[""],"_ez-toc-insert":[""],"_ez-toc-header-label":[""],"_ez-toc-alignment":["none"],"_ez-toc-heading-levels":["a:0:{}"],"_ez-toc-alttext":[""],"_ez-toc-visibility_hide_by_default":[""],"_ez-toc-hide_counter":[""],"_ez-toc-exclude":[""],"_ez-toc-position-specific":["before"],"stm_select_gm_zoom":[""],"stm_agenda":[""],"stm_host":[""],"stm_select_approved_denied":[""],"stm_multiselect_approved":[""],"stm_multiselect_denied":[""],"stm_date":[""],"stm_time":[""],"stm_timezone":[""],"stm_duration":[""],"stm_password":[""],"stm_waiting_room":[""],"stm_join_before_host":[""],"stm_host_join_start":[""],"stm_start_after_participants":[""],"stm_mute_participants":[""],"stm_enforce_login":[""],"stm_alternative_hosts":[""],"top_bar_custom_style":[""],"top_bar_bg":[""],"wc_top_bar_cart_custom_style":[""],"wc_top_bar_cart_color":[""],"wc_top_bar_cart_icon_color_hover":[""],"wc_top_bar_cart_counter_color":[""],"wc_top_bar_cart_counter_color_hover":[""],"wc_top_bar_cart_counter_bg":[""],"wc_top_bar_cart_counter_bg_hover":[""],"top_bar_wpml_switcher_custom_style":[""],"wpml_switcher_color":[""],"top_bar_wpml_switcher_bg":[""],"top_bar_wpml_switcher_bg_hover":[""],"top_bar_wpml_switcher_color_hover":[""],"top_bar_socials_custom_style":[""],"top_bar_socials_color":[""],"top_bar_socials_color_hover":[""],"top_bar_search_custom_style":[""],"top_bar_search_color":[""],"top_bar_search_icon_color_hover":[""],"top_bar_contact_info_style":[""],"top_bar_contact_info_color":[""],"top_bar_contact_info_link_color":[""],"top_bar_contact_info_link_color_hover":[""],"top_bar_contact_info_select_bg":[""],"top_bar_contact_info_select_color":[""],"top_bar_contact_info_select_drop_bg":[""],"top_bar_contact_info_select_items_bg":[""],"top_bar_contact_info_select_items_color":[""],"top_bar_contact_info_select_items_hover":[""],"header_inverse":["default"],"enable_header_transparent":["off"],"header_nav_custom_style":[""],"header_bg":[""],"header_shadow":[""],"wc_cart_custom_style":[""],"wc_cart_icon_color":[""],"wc_cart_icon_color_hover":[""],"wc_cart_counter_color":[""],"wc_cart_counter_color_hover":[""],"wc_cart_counter_bg":[""],"wc_cart_counter_bg_hover":[""],"header_wpml_switcher_custom_style":[""],"header_wpml_switcher_color":[""],"header_wpml_switcher_color_hover":[""],"header_wpml_switcher_bg":[""],"header_wpml_switcher_bg_hover":[""],"header_socials_custom_style":[""],"header_socials_color":[""],"header_socials_color_hover":[""],"header_search_custom_style":[""],"header_search_icon_color":[""],"header_search_icon_color_hover":[""],"header_contact_info_style":[""],"header_contact_info_color":[""],"header_contact_info_link_color":[""],"header_contact_info_link_color_hover":[""],"header_button_custom_style":[""],"header_button_color":[""],"header_button_color_hover":[""],"header_button_bg":[""],"header_button_bg_hover":[""],"header_nav_menu_customize":[""],"header_nav_menu_link_color":[""],"header_nav_menu_link_color_hover":[""],"header_nav_menu_link_color_active":[""],"header_nav_menu_link_arrow_color":[""],"header_nav_menu_link_arrow_color_hover":[""],"header_nav_menu_level_1_bg":[""],"header_nav_menu_level_1_link_color":[""],"header_nav_menu_level_1_link_color_hover":[""],"header_nav_menu_level_1_link_bg_hover":[""],"header_nav_menu_level_1_link_arrow_color":[""],"header_nav_menu_level_1_link_arrow_color_hover":[""],"header_nav_menu_level_2_bg":[""],"header_nav_menu_level_2_link_color":[""],"header_nav_menu_level_2_link_color_hover":[""],"header_nav_menu_level_2_link_bg_hover":[""],"header_mega_menu_bg":[""],"header_mega_menu_title_color":[""],"header_mega_menu_title_color_hover":[""],"header_mega_menu_description_color":[""],"header_mega_menu_description_link_color":[""],"header_mega_menu_description_link_color_hover":[""],"header_mega_menu_color":[""],"header_mega_menu_color_hover":[""],"header_mega_menu_border_color":[""],"header_mega_menu_icons_color":[""],"header_nav_menu_customize_end":[""],"hfe_enabled_notice":[""],"disable_title_box":["default"],"hfe_disabled":[""],"enable_transparent":["default"],"title_box_title_bg_color":[""],"title_box_bg_custom_image":["default"],"title_box_bg_image":[""],"title_box_bg_position":["default"],"metabox_title_box_bg_position_x":[""],"metabox_title_box_bg_position_y":[""],"metabox_title_box_bg_attachment":["default"],"title_box_bg_size":["default"],"metabox_title_box_bg_size_slider":[""],"title_box_bg_repeat":["default"],"disable_title":["default"],"title_box_title_color":[""],"title_box_title_line_color":[""],"disable_breadcrumbs":["default"],"metabox_title_box_breadcrumbs_color":[""],"metabox_title_box_links_color":[""],"metabox_title_box_links_color_hover":[""],"content_bg_transparent":[""],"show_popup_single":[""],"popups_single":[""],"popups_single_event":[""],"popup_single_event_open_delay":[""],"popup_single_event_showing_in":[""],"popup_single_event_date_from":[""],"popup_single_event_date_to":[""],"popup_single_event_time_from":[""],"popup_single_event_time_to":[""],"popup_single_animation":[""],"popup_single_responsive":[""],"separator_footer_copyright_border_t":[""],"name":[""],"email":[""],"phone":[""],"company":[""],"memberId":[""],"testimonial_position":[""],"testimonial_company":[""],"testimonial_bg_img":[""],"testimonial_video_url":[""],"popups_width":[""],"popups_height":[""],"popups_image_bg":[""],"popups_color_bg":[""],"popups_border_radius":[""],"popups_template":[""],"rank_math_analytic_object_id":["42340"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/09\/dr-agarwals-health-care-q2-results-fy27-preview-date-expectations-1.png","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/236242","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/29"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=236242"}],"version-history":[{"count":2,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/236242\/revisions"}],"predecessor-version":[{"id":236258,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/236242\/revisions\/236258"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/236241"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=236242"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=236242"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=236242"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}